Skip to main content
Fig. 3 | Systematic Reviews

Fig. 3

From: Redefining outcomes of ventricular arrhythmia for SGLT2 inhibitor medication in heart failure patients: a meta-analysis of randomized controlled trials

Fig. 3

Subgroup analysis of the effects of various drugs and durations on the efficacy of SGLT-2 inhibitors in reducing the incidence of ventricular arrhythmias. A Effects of different sodium‒glucose cotransporter-2 inhibitors on the incidence of ventricular arrhythmias. B The duration of pharmacotherapy influences the effectiveness of SGLT2 inhibitors in reducing the incidence of ventricular arrhythmias

Back to article page

Systematic Reviews

ISSN: 2046-4053